ABO-Incompatible Living Donor Liver Transplantation from Hepatitis B Core Antibody Positive Donor to Hepatitis C Liver Cirrhosis Recipient: A Case Report

<table>Major treatments, events, and laboratory results in the clinical course. Panel shows a timeline of the recipient’s clinical course until discharge, with arrows indicating points of administration of rituximab and HBIG. Periods of steroids, MMF, PVIT, tacrolimus, and entecavir are indicated by the gray bars. Results of CD19- and CD20-positive B cell count, isoagglutinin titers of anti-A and anti-B, and HBs-Ab are shown below the graph.</table>

Case Reports in Transplantation

fig1

Figure 1

Figure 1: ABO-Incompatible Living Donor Liver Transplantation from Hepatitis B Core Antibody Positive Donor to Hepatitis C Liver Cirrhosis Recipient: A Case Report 

Figure 1 | ABO-Incompatible Living Donor Liver Transplantation from Hepatitis B Core Antibody Positive Donor to Hepatitis C Liver Cirrhosis Recipient: A Case Report 